Recent advances in peroxisome proliferator-activated receptor science

Current Medicinal Chemistry

Volumn 10, Issue 4, 2003, Pages 267-280

  Shearer, Barry G ^a   Hoekstra, William J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BEZAFIBRATE; BUCLADESINE; BUTYRIC ACID DERIVATIVE; CELL NUCLEUS RECEPTOR; CIPROFIBRATE; CLOFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; GW 0072; LIGAND; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; NETOGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIOGLITAZONE; PIRINIXIC ACID; RECEPTOR SUBTYPE; REGLITAZAR; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BODY WEIGHT DISORDER; BONE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; DYSLIPIDEMIA; EDEMA; GENE EXPRESSION REGULATION; GLUCOSE UTILIZATION; HUMAN; LIGAND BINDING; LIPID METABOLISM; LIVER TOXICITY; METABOLIC DISORDER; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; RECEPTOR UPREGULATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0037238924     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033368295     Document Type: Review

References (113)

1. Willson, T. M.; Brown, P. J.; Sternbach, D. D.; Henke, B. R. J. Med. Chem. 2000, 43, 527-550.
2. Kersten, S.; Wahli, W. New Approaches to Drug Development, P. Jolles, Ed.; Birkhauser Verlag, Switzerland (2000).
3. Jones, A. B. Medicinal Research Reviews 2001, 21, 540-552.
4. Winegar, D. A.; Su, J.-L.; Kliewer, S. A. Curr. Opin. Card. Pulm. Renal Invest. Drugs 2000, 2, 233-243.
5. Sher, T.; Yi, H. F.; McBride, O. W.; Gonzalez, F. J. Biochemistry 1993, 32, 5598-5604.
6. Brown, P. J.; Winegar, D. A.; Plunket, K. D.; Moore, L. B. J. Med. Chem. 1999, 42, 3785-3788.
7. Xu, H. E.; Stanley, T. B.; Montana, V. G.; Lambert, M. H. Nature 2002, 415, 813-817.
8. Miyachi, H.; Murakami, K. PCT Int'l Patent Applications WO0244127, WO0244129, WO0244130, WO0244131, WO0246146.
9. Issemann, I.; Green, S. Nature 1990, 347, 645-650.
10. Ross, S. D.; Allen, I. E.; Connelly, J. E.; Korenblat, B. M. Arch. Intern. Med. 1999, 159, 1793-1802.
11. Brown, P. J.; Stuart, L. W.; Hurley, K. P.; Lewis, M. C. Bioorg. Med. Chem. Lett. 2001, 11, 1225-1227.
12. Marx, N.; Sukhova, G. K.; Collins, T.; Libby, P. Circulation 1999, 99, 3125-3131.
13. Spencer, N. F. L.; Poynter, M. E.; Im, S.-Y.; Daynes, R. A. Int. Immunol. 1997, 9, 1581-1588.
14. Chinetti, G.; Griglio, S.; Antonucci, M.; Torra, I. P. J. Biol. Chem. 1998, 273, 25573-25580.
15. Cabrero, A.; Llaverias, G.; Roglans, N.; Alegret, M. Biochem. Biophys. Res. Commun. 1999, 260, 547-556.
16. Krook, A.; Digby, J.; O'Rahilly, S.; Zierath, J. R. Diabetes 1998, 47, 1528-1531.
17. Etgen, G. J.; Oldham, B. A.; Johnson, W. T.; Broderick, C.L. Diabetes 2002, 51, 1083-1087.
18. Brooks, D. A. Etgen, G. J.; Rito, C. J.; Shuker, A. J. J. Med. Chem. 2001, 44, 2061-2064.
19. Fruchart, J.-C.; Staels, B.; Duriez, P. Pharm. Research 2001, 44, 345-352.
20. Mukherjee, R.; Jow, L.; Croston, G. E.; Paterniti, J. R. J. Biol. Chem. 1997, 272, 8071-8076.
21. Spiegelman, B. M. and Flier, J.S. Curr. Opin. Cell Biol. 1996, 87, 377-389.
22. Xu, H. E.; Lambert, M. H.; Montana, V. G.; Parks, D. J. Mol. Cell 1999, 3, 397-403.
23. Huang, J. T.; Welch, J. S.; Ricote, M.; Binder, C. J. Nature 1999, 400, 378-382.
24. Nagy, L.; Tontonoz, P.; Alvarez, J. G. A.; Chen, H. Cell 1998, 93, 229-240.
25. Hulin, B.; McCarthy, P. A.; Gibbs, E. M. Curr Pharm. Design 1996, 2, 85-102.
26. Buckle, D. R.; Cantello, B. C. C.; Cawthorne, M. A.; Coyle, P.J. Bioorg. Med. Chem. Lett. 1996, 6, 2121-2126.
27. Young, P. W.; Buckle, D. R.; Cantello, B. C. C.; Chapman, H. J. Pharmacol. Exp. Ther. 1998, 284, 751-759.
28. Henke, B. R.; Blanchard, S. G.; Brackeen, M. F.; Brown, K.K. J. Med. Chem. 1998, 41, 5020-5036.
29. Collins, J. L.; Blanchard, S. G.; Boswell, G. E.; Charifson, P. S. J. Med. Chem. 1998, 41, 5037-5054.
30. Cobb, J. E.; Blanchard, S. G.; Boswell, G. E.; Brown, K. K. J. Med. Chem. 1998, 41, 5055-5069.
31. Fiedorek, F. T. Diabetes Res. CI. Pract. 2000, 50 (Suppl. 1), S40.
32. Wilson, G. G. Diabetes 2000, 49 (Suppl. 1), Abstr. 158-OR.
33. Shinkai, H.; Onogi, S.; Tanaka, M.; Shibata, T. J. Med. Chem. 1998, 41, 1927-1933.
34. Murakami, K.; Tobe, K.; Ide, T.; Mochizuki, T. Diabetes 1998, 47, 1841-1847.
35. Oberfield, J. L.; Collins, J. L.; Holmes, C. P.; Goreham, D.M. Proc. Natl. Acad. Sci. USA 1999, 96, 6102-6106.
36. Willson, T. M.; Lambert, M. H.; Kliewer, S. A. Ann. Rev. Biochem. 2001, 70, 341-367.
37. Reginato, M. J.; Bailey, S. T.; Krakow, S. L.; Minami, C. J. Biol. Chem. 1998, 273, 32679-32684.
38. Fukui, Y.; Masui, S.; Kazuhiko, K.; Motojima, K. Diabetes 2000, 49, 759-767.
39. Miyahara, T.; Schrum, L.; Rippe, R.; Xiong, S. J. Biol. Chem. 2000, 275, 35715-35722.
40. Lee, G.; Elwood, F.; McNally, J.; Weiszmann, J. J. Biol. Chem. 2002, 277, 19649-19657.
41. Camp, H. S.; Chaudhry, A.; Leff, T. Endocrinology 2001, 142, 3207-3213.
42. Mukherjee, R.; Hoener, P. A.; Jow, L.; Bilakovics, J. Mol. Endocrinol. 2000, 14, 1425-1433.
43. Wright, H. M.; Clish, C. B.; Mikami, T.; Hauser, S. J. Biol. Chem. 2000, 275, 1873-1877.
44. Wang, Y.; Porter, W. W.; Sub, N.; Honda, T. Mol. Endocrinol. 2000, 14, 1550-1556.
45. Grossman, S. L., Lessem, J. Expert Opin. Invest. Drugs 1997, 6, 1025-1040.
46. Ikeda, H.; Taketomi, S.; Sugiyama, Y.; Shimura, Y. Arzneim.-Forsch. 1990, 40, 156-162.
47. Hallakou, S.; Foufelle, F.; Doare, L.; Kergoat, M. Diabetologia 1998, 41, 963-968.
48. Randle, P. J. Diabetes Metab. Rev. 1998, 14, 263-283.
49. Hallakou, S.; Doare, L.; Foufelle, F.; Kergoat, M. Diabetes 1999, 46, 1393-1399.
50. Okuno, A.; Tamemoto, H.; Tobe, K.; Ueki, K. J. Clin. Invest. 1998, 101, 1354-1361.
51. Way, J. M.; Harrington, W. W.; Brown, K. K.; Gottschalk, W. K. Endocrinology 2001, 142, 1269-1277.
52. Vidal-Puig, A.; Jimenez-Linan, M.; Lowell, B. B.; Hamann, A. J. Clin. Invest. 1996, 97, 2553-2561.
53. Vidal-Puig, A.; Considine, R. V.; Jimenez-Linan, M.; Werman, A. J. Clin. Invest. 1997, 99, 2416-2422.
54. Tontonoz, P.; Nagy, L.; Alvarez, J. G. A.; Thomazy, V. A. Cell 1998, 93, 241-252.
55. Li, A. C.; Brown, K. K., Silvestre, M. J.; Willson, T. M. J. Clin. Invest. 2000, 106, 523-531.
56. Minamikawa, J.; Tanaka, S.; Yamauchi, M.; Inoue, D. J. Clin. Endocrinol. Metab. 1998, 83, 1041-1042.
57. Repa, J. J.; Turley, S. D.; Lobaccaro, J. M. A.; Medina, J. Science 2000, 289, 1524-1529.
58. Chawla, A.; Schwarz, E. J.; Dimaculangan, D. D.; Lazar, M.A. Mol. Cell 2001, 7, 161-171.
59. Debril, M. B.; Renaud, J. P.; Fajas, L.; Auwerx, J. J. Mol. Med. 2001, 79, 30-47.
60. Gelman, L.; Fruchart, J-C.; Auwerx, J. Cell Mol. Life Sci. 1999, 55, 932-943.
61. Chinetti, G.; Fruchart, J-C.; Staels, B. Inflam. Res. 2000, 49, 497-505.
62. Ricote, M.; Li, A. C.; Willson, T. M.; Kelly, C. J. Nature 1998, 391, 79-82.
63. Su, C. G.; Wen, X.; Bailey, S. T.; Jiang, W. J. Clin. Invest. 1999, 104, 383-389.
64. Bordji, K.; Grillasca, J. P; Gouze, J. N.; Magdalou, J. J. Biol. Chem. 2000, 275, 12243-12250.
65. Tontonoz, P.; Singer, S.; Forman, B. M. Sarraf, P. Proc. Natl. Acad. Sci. USA 1997, 94, 237-241.
66. Mueller, E.; Sarraf, P.; Tontonoz, P.; Evans, R. M. Mol Cell 1998, 1, 465-470.
67. Sarraf, P.; Mueller, E.; Jones, D.; King, F.J. Nat. Med. 1998, 4, 1046-1052.
68. Brockman, J. A.; Gupta, R. A.; DuBois, R. N. Gastroenterology 1998, 115, 1049-1055.
69. Chang, T. H.; Szabo, E. Cancer Res. 2000, 60, 1129-1138.
70. Tsubouchi, Y.; Sano, H.; Kawahito, Y.; Mukai, S. Biochem. Biophys. Res. Commun. 2000, 270, 400-405.
71. Kubota, T.; Koshizuka, K.; Williamson, E. A.; Asou, H. Cancer Res. 1998, 58, 3344-3352.
72. Guan, Y. F.; Zhang, Y. H.; Breyer, R. M.; Davis, L. Neoplasia 1999, 1, 330-339.
73. Gastri Takahashi N.; Okumuro, T.; Motomura, W. Fujimoto, Y. FEBS Lett. 1999, 455, 135-139.
74. Murphy, G.J.; Holder, J.C. Trends Pharmacol. Sci. 2000, 21, 469-474.
75. Roberts-Thomson, S.J. Immunol Cell Biol. 2000, 78, 436-441.
76. Demetri, G. D.; Fletcher, C. D. M.; Mueller, E.; Sarraf, P. Proc. Natl. Acad. Sci. USA 1999, 96, 3951-3956.
77. Elstner, E.; Muller, C.; Koshizuka, K.; Williamson, E. A. Proc. Natl. Acad. Sci. USA 1998, 95, 8806-8811.
78. Clay, C. E.; Namen, A. M.; Atsumi, G-I.; Willingham, M.C. Carcinogenesis 1999, 20, 1905-1911.
79. Su, N.; Wang, Y.; Williams, C. R.; Risingsong, R. Cancer Res. 1999, 59, 5671-5673.
80. Lefebvre, A.M.; Chen, I.; Desreumaux, P.; Nahib, J. Nat. Med. 1998, 4, 1053-1057.
81. Saez, E.; Tontonoz, P.; Nelson, M. C.; Alvarez, J. G. A. Nat. Med. 1998, 4, 1058-1061.
82. Schmidt, A.; Endo, N.; Rutledge, S. J.; Vogel, R. Mol. Endocrinol. 1992, 6, 1634-1641.
83. Oliver, W. R.; Shenk, J. L.; Snaith, M. R.; Russell, C. S. Proc. Natl. Acad. Sci. USA 2001, 98, 5306-5311.
84. Hansen, J. B.; Zhang, H.; Rasmussen, T.H.; Petersen, R.K. J. Biol. Chem. 2001, 276, 3175-3182.
85. He, T. C.; Chan, T. A.; Vogelstein, B.; Kinzler, K. W. Cell 1999, 99, 335-345.
86. Mano, H.; Kimura, C.; Fujisawa, Y.; Kameda, T. J. Biol. Chem. 2000, 275, 8126-8132.
87. Lim, H.; Gupta, R. A.; Ma, W. G.; Paria, B. C. Genes Dev. 1999, 13, 1561-1574.
88. Peters, J.M.; Lee, S. S.; Li, W. Ward, J. M. Mol. Cell Biol. 2000, 20, 5119-5128.
89. Michalik, L.; Desvergne, B. Tan, N. S. J. Cell. Biol. 2001, 154, 799-814.
90. Chao, E. Y.; Haffner, C. D.; Lambert, M. H.; Maloney, P. R. PCT Int'l Patent Application WO0100603.
91. Berger, J.; Leibowitz, M. D.; Doebber, T. W.; Elbrecht, A. J. Biol. Chem. 1999, 274, 6718-6725.
92. Leibowitz, M. D.; Berger, J. P.; Moller, D. E.; Auwerx, J. PCT Int'l Patent Application WO9728149.
93. Leibowitz, M. D.; Fievet, C.; Hennuyer, N. Peinado-Onsurbe, J. FEBS Lett. 2000, 473, 333-336.
94. Winegar, D. A.; Brown, P. J.; Wilkison, W. O.; Lewis, M.C. J. Lipid Res. 2001, 42, 1543-1551.
95. Liu, K. G.; Lambert, M. H.; Leesnitzer, L. M.; Oliver, W. R. Bioorg. Med. Chem. Lett. 2001, 11, 2959-2962.
96. Barak, Y.; Liao, D.; He,, W.; Ong, E. S. Proc. Natl. Acad. Sci. USA 2002, 99, 303-308.
97. He, T.-C.; Chan, T. A.; Vogelstein, B.; Kinzler, K. W. Cell 1999, 99, 335-345.
98. DuBois, R. N.; Giardiello, F. M.; Smalley, W. E. Gastroenterol. Clin. North Am. 1996, 25, 773-791.
99. Park, B. H.; Vogelstein, B.; Kinzler, K. W. Proc. Natl. Acad. Sci. USA 98, 2598-2603 (2001).
100. Jackson, S. M.; Demer, L. L. FEBS Lett. 2000, 471, 119-124.
101. UK Prospective Diabetes Study Group. Lancet 1998, 352, 837-853.
102. Auwerx, J. Insulin Resist., Metab. Dis. Diabetic Complications 1999, 1177, 167-172.
103. Chaput, E.; Saladin, R.; Silvestre, M.; Edgar, A. D. Biochem. Biophys. Res. Comm. 2000, 271, 445-450.
104. Lohray, B. B.; Lohray, V. B.; Bajji, A. C.; Kalchar, S. J. Med. Chem. 2001, 44, 2675.
105. Oakes, N. Abstract 446-P, 62nd Sci. Sess. Am. Diabetes Assoc., June 14-18, 2002.
106. Cheng, P. T. Abstract 381-P, 62nd Sci. Sess. Am. Diabetes Assoc., June 14-18, 2002.
107. Nolte, R.T.; Wisely, G. B.; Westin, S.; Cobb, J. E. Nature 1998, 395, 137-143.
108. Uppenberg, J.; Svensson, C.; Jaki, M.; Bertilsson, G. J. Biol. Chem. 1998, 273, 31108-31112.
109. Gampe, R.T., Jr.; Montana, V. G.; Lambert, M. H.; Miller, A. B. Mol. Cell 2000, 5, 545-555.
110. Xu, H.E.; Lambert, M. H.; Montana, V. G.; Plunket, K. D. Proc. Natl. Acad. Sci. USA 2001, 98, 13919-13924.
111. For a recent review on the mechanisms of action of the PPARS, see Berger, J.; Moller, D. E. Ann. Rev. Med. 2002, 53, 409-435.
112. For a recent review on PPARγ ligands in development, see Leff, T.; Reed, J. E. Curr. Med. Chem. - Immun., Endoc. & Metab. Agents 2002, 2, 33-47.
113. For a recent review on PPAR modulators and chemoprevention, see Kopelovich, L.; Fay, J. R.; Glazer, R. I.; Crowell, J. A. Mol. Cancer. Ther. 2002, 1, 357-363.